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Abstract: Dietary modifications leading to weight loss have been suggested as a means to improve
brain health. In morbid obesity, bariatric surgery (BARS)—including different procedures, such
as vertical sleeve gastrectomy (VSG), gastric banding (GB), or Roux-en-Y gastric bypass (RYGB)
surgery—is performed to induce rapid weight loss. Combining reduced food intake and malabsorption
of nutrients, RYGB might be most effective, but requires life-long follow-up treatment. Here, we tested
40 patients before and six months after surgery (BARS group) using a neuropsychological test battery
and compared them with a waiting list control group. Subsamples of both groups underwent
structural MRI and were examined for differences between surgical procedures. No substantial
differences between BARS and control group emerged with regard to cognition. However, larger
gray matter volume in fronto-temporal brain areas accompanied by smaller volume in the ventral
striatum was seen in the BARS group compared to controls. RYGB patients compared to patients
with restrictive treatment alone (VSG/GB) had higher weight loss, but did not benefit more in
cognitive outcomes. In sum, the data of our study suggest that BARS might lead to brain structure
reorganization at long-term follow-up, while the type of surgical procedure does not differentially
modulate cognitive performance.
Keywords: Roux-en-Y gastric bypass; executive functions; voxel-based morphometry; fronto-temporal
cortex; nucleus accumbens
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1. Introduction
Obesity and overweight have been increasing dramatically in most countries around the world
and constitute a major health problem [1]. In particular, obesity increases the risk for diseases, such as
type 2 diabetes, hypertension, coronary heart disease, and stroke [2]. Moreover, it is associated with
the reduced cognitive performance [3,4], and even with dementia in later life [5].
Conversely, dietary modifications leading to weight loss have been suggested as a means to
improve brain health (for reviews and putative cellular mechanisms, such as the engagement of
adaptive cellular stress response pathways, see Reference [6,7]). Evidence from studies in humans,
however, is scarce (for a review and metaanalysis, see Reference [8]). In a previous study [9], we found
that intense weight loss after a low caloric diet in older women with obesity was associated with
improved cognition (e.g., executive functions) paralleled by increased gray matter (GM) volume in
inferior frontal gyrus and hippocampus.
One highly effective means leading to rapid and sustainable weight loss in obesity is bariatric
surgery (BARS). BARS leads to an average long-term weight loss of 10–25% [10], and thus, surpasses
other treatment opportunities, such as nutritional counseling and sport interventions [11]. Approaches
include gastric banding (GB), vertical sleeve gastrectomy (VSG), and gastric bypass surgeries, most
often the Roux-en-Y gastric bypass (RYGB). While GB and VSG only restrict the amount of food
that can be consumed (purely restrictive treatment), an RYGB is built to circumvent large parts of
the gastrointestinal tract [12], and leads to both restrictions of food intake and malabsorption of
nutrients (combined restrictive-malabsorptive treatment). In addition to weight loss and recovery from
obesity-related diseases, a number of studies showed improved cognitive function after BARS (e.g.,
References [13–16]). Although most studies documented improvement in at least one neurocognitive
domain, such as executive functions, memory, or attention, they were not unequivocal and consistent
(for reviews, see References [17–20]). Georgiadou et al. [21], for instance, was unable to find any
substantial differences in cognitive assessments comparing 50 post-RYGB patients to a well-matched
sample of patients seeking BARS. Although patients treated with a combined restrictive-malabsorptive
approach (i.e., RYGB) show greater and faster weight loss, as well as faster improvement in glucose
control than patients treated with purely restrictive procedures (i.e., VSG and GB; [22]), it is unclear
whether this approach also benefits patients more with regard to brain health. For instance, it has been
suggested that the surgical removal of parts of the gut with hormonal activity might also affect brain
structure and function [23], (for a review, see Reference [24]). Smith et al. [25] compared cognitive
functions in RYGB and VSG patients before and after surgery and found improvements in executive
functions and processing speed in both groups. RYGB patients also exhibited improved attention, but
no group × time interactions were reported.
In the present study, we tested cognitive performance in patients before and six months after BARS
using a comprehensive neuropsychological testing battery (primary outcome parameter: Composite
executive functions score; see Reference [9]). The same cognitive performance test was done in a patient
group waiting for BARS at similar time points. We expected that patients undergoing BARS compared
to controls would show improved executive control together with further improvements in memory,
mood/affect and health-related quality of life [9]. Since intervention-induced regional changes in GM
volume have been found to correlate and precede possible improvement in cognitive functions [9,26–28],
GM volume was measured at both time points in all patients eligible for magnetic resonance imaging
(MRI) as a task-independent sensitive and reliable biomarker. In particular, we expected that BARS
patients would show an increase of GM volume in the fronto-temporal cortex [9,29]. Finally, we explored
the question of differences in cognitive outcomes between surgical procedures.
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2. Materials and Methods
2.1. Study Overview
The study employed a prospective and longitudinal observational study design and was conducted
at Charité—Universitätsmedizin Berlin. Forty patients scheduled for BARS (BARS group) were tested
before (t1) and six months after the intervention (t2) in a range of cognitive domains, including
executive functions (primary outcome), memory, and attention and compared to a waiting list control
group at similar time points (NBARS group; n = 29). From these 69 patients, 27 were also eligible for
structural magnetic resonance imaging (MRI; BARS group: n = 13, NBARS group: n = 14) at both time
points. In addition, blood samples were taken, and anthropometric data, such as height, weight, blood
pressure, and body fat percentage were recorded. In a second step, BARS patients were compared with
regard to whether surgical procedures were purely restrictive (VSG/GB group, n = 23) or combined
restrictive-malabsorptive (RYGB group, n = 17). For an overview of the study flow, see Figure 1.
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Figure 1. Study flow. Eighty-two patients with obesity were recruited and assigned to bariatric surgery
(BARS) or waiting for control group (NBARS group) based on whether they had already been scheduled
for surgery, or whether they could not be scheduled within the next six months, respectively. Forty
patients in the BARS (28 women, mean age = 46 ± 11 years) and 29 patients in the NBARS group
(16 women; mean age = 45 ± 12 years) underwent baseline and follo -up measureme ts, including
edical examination and neuropsychological testi g. Thirteen patients in the BARS and 14 tie ts i
t NBARS group also underw nt structural MRI. We also looked for effects of surgical procedures
and divided surgery patients into two groups [purely restrictive treatment (n = 23): VSG/GB group;
combined restrictive-malabsorptive treatme t (n = 17): RYGB group].
2.2. Participants
All participants were recruited from the Center for Bariatric and Metabolic Surgery at
Charité—Universitätsmedizin Berlin. Inclusion criteria comprised age between 18 and 70 years
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and formal requirements for BARS according to the BARS guidelines: Patients must either have
(1) a BMI greater than 40 kg/m2 and failure of conservative obesity treatment or (2) a BMI greater than
35 kg/m2, at least one typical co-morbidity (such as type-2 diabetes, hypertension, non-alcoholic fatty
liver disease), and failure of conservative obesity treatment. Exclusion criteria included the history of
severe untreated medical, neurological, and psychiatric diseases, brain pathologies identified in the
MRI scan, and non-fluent German language abilities. A mini mental state examination (MMSE; [30])
score below 24, indicating cognitive impairment [31], was also set as an exclusion criterion.
Since a sample size calculation conducted prior to the study revealed that 40 subjects per group
are needed to detect a difference in the primary outcome parameter between the groups at t2 with
moderate effect size, 82 subjects were recruited into the study (based on inclusion and exclusion criteria
detailed above). Subjects recruited into the study were either assigned to the BARS or to the NBARS
group based on whether they had already been scheduled for surgery, or whether they could not be
scheduled within the next six months, respectively. The waiting time of more than six months in the
NBARS group gave us the time to carry out baseline and follow-up measurements before surgery.
Although patients were not randomly assigned, groups did not differ with regard to key baseline
characteristics. First, all patients included into the study were eligible for bariatric surgery: After
careful evaluation by the treating physicians (psychiatrist and surgeon), waiting list group patients
had been recommended to undergo bariatric surgery, but had to wait for this procedure, due to the
prolonged process of receiving approval by health insurances in Germany. Second, demographic and
health-related parameters, such as age, gender, educational level, verbal intelligence, and depression
score were comparable, except for BMI which was 4 kg/m2 higher in the BARS group (see Section 3 on
the analysis of baseline characteristics and Table 1(a)).
Table 1. Baseline characteristics [mean (SD)] (a) for the whole sample (NBARS vs. BARS group),
(b) for the MRI sample (NBARS vs. BARS group), and (c) for the comparison of the different surgical
procedures (purely restrictive: VSG/GB group vs. combined restrictive-malabsorptive: RYGB group).
Changes with p ≤ 0.05 between groups are indicated by underscoring the numbers.
(a) Whole Sample
NBARS Group BARS Group p
n 29 40
Age (years) 45 (12) 46 (11) 0.61
Gender (% women) 55.2 70.0 0.21 a
Weight (kg) 133.2 (22.6) 140.9 (29.3) 0.24
BMI (kg/m2) 44.6 (5.7) 49.2 (7.7) 0.01
Education (years) 16 (3) 15 (4) 0.66
Verbal intelligence (vocabulary test score) 29.8 (3.4) 29.7 (3.11) 0.66
BDI (Beck’s depression inventory score) 14.6 (7.3) c 13.1 (9.3) b 0.51
Fasting glucose (mg/dL) 117.8 (33.2) d 127.4 (62.5) 0.46
HbA1c (%) 6.1 (1.0) d 6.3 (1.1) 0.44
(b) MRI Sample
NBARS Group BARS Group p
n 14 13
Age (years) 47 (12) 41 (11) 0.15
Gender (% women) 57.1 84.6 0.12 a
Weight (kg) 123.7 (14.9) 123.8 (16.4) 0.98
BMI (kg/m2) 42.5 (4.7) 44.5 (5.6) 0.30
Education (years) 15.5 (2.3) 15.3 (3.0) 0.88
Verbal intelligence (vocabulary test score) 30.2 (3.3) 29.5 (2.5) 0.56
BDI (Beck’s depression inventory score) 16.2 (6.6) d 17.3 (13.2) 0.78
Fasting glucose (mg/dL) 113.8 (26.6) d 130.8 (93.6) 0.54
HbA1c (%) 6.0 (1.1) d 6.2 (1.1) 0.70
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Table 1. Cont.
(c) Comparison of Surgical Procedures
VSG/GB Group RYGB Group p
n 23 17
Age (years) 47 (11) 45 (10) 0.71
Gender (% women) 57 88 0.03 a
Weight (kg) 147.8 (29.3) 131.6 (27.5) 0.08
BMI (kg/m2) 50.2 (8.5) 47.7 (6.5) 0.31
Education (years) 15 (4) 16 (4) 0.29
Verbal intelligence (vocabulary test score) 30.2 (2.5) 29.1 (3.8) 0.25
BDI (Beck’s depression inventory score) 14.0 (9.1) d 11.9 (9.7) d 0.51
Fasting glucose (mg/dL) 133.8 (79.2) 118.7 (27.7) 0.46
HbA1c (%) 6.3 (1.1) 6.2 (1.0) 0.66
a Calculated with χ2-test. b Data was not available for two subjects. c Data was not available for five subjects. d Data
was not available for one subject.
Unfortunately, the recruitment of patients to the NBARS group from the Center for Bariatric and
Metabolic Surgery turned out to be more difficult than expected, since most patients interested in
participating were already scheduled for surgery. Additionally, we were confronted with a rather high
number of participants that dropped out of the study, especially in the NBARS group. Five patients in
the BARS and seven patients in the NBARS group did not complete the study, due to personal reasons,
such as time constraints or change of residence. Finally, we had to exclude one additional patient from
the waiting list control group, because he changed his lifestyle quite markedly, thus, lost more than
15% of his initial weight during the waiting period and was no longer eligible for BARS, leaving only
69 participants for the analysis (BARS group: n = 40, 28 women; NBARS group: n = 29, 16 women).
MRI scanning was possible in 13 patients of the BARS and 14 patients of the NBARS group.
The remaining patients did not tolerate scanning, either due to claustrophobia or to the size of the MR
bore (diameter of 60 cm only).
From the 40 patients in the BARS group, 17 were treated with RYGB (combined restrictive-
malabsorptive or RYGB group), while 23 patients underwent VSG (n = 22) or GB (n = 1), and thus,
were assigned to the “purely restrictive” or VSG/GB group.
The research protocol was approved by the local Institutional Review Board of the
Charité—Universitätsmedizin Berlin (ethical approval code: EA1/074/11). The study was carried out in
accordance with the principles of the Declaration of Helsinki. All subjects provided written informed
consent before the investigation and received a small reimbursement for their participation.
2.3. Assessment of Neuropsychological and Physical Data
Assessment of neuropsychological and physical data at t1 and t2 was done by a research assistant
trained in clinical neuropsychology. Subjects arrived in the morning (between 07:00 and 12:00) after
an overnight fast. First, they underwent a standardized medical interview, including a neurological
examination. After blood sampling and measurement of anthropometric parameters (i.e., body weight,
height, BMI, systolic and diastolic blood pressure, body fat percentage), subjects were given around
one hour time for breakfast. After the break, they were tested using a comprehensive test battery
with a focus on executive functions (primary outcome parameter), memory, sensomotor speed, and
attention. Finally, MRI scanning was done, if possible, despite high weight (patients were not eligible
for the MRI part of the study if contraindications for MRI were present).
For measuring executive functions, the test battery included phonematic and semantic verbal
fluency [32], the trail making test (TMT) part A and B [33], and the Stroop color-word interference
test [17]. Memory was assessed with the German version of the auditory verbal learning test
(VLMT; [18]) and digit span backwards. Subscores of the TMT, Stroop, and the digit span task were
used to provide measures of sensomotor speed and attention.
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In particular, phonematic verbal fluency was measured by the average number of words with the
initial letter “S” and “P” a subject was able to produce in one minute. To measure semantic fluency,
the categories “animal species” and “given names” were chosen.
The trail making test (TMT) comprised two parts. In part A, subjects were instructed to connect
numbers from 1 to 25 on a sheet of paper in sequential order as quickly as possible. In part B, subjects
had to alternate between numbers and letters (1, A, 2, B, etc.). The time to complete each part was
taken as testing scores.
The Stroop (color-word interference) test comprised three parts. In part 1, subjects had to read as
quickly as possible a list of color names (“red,” “yellow,” “green,” and “blue”). In part 2, subjects had
to identify the color of printed bars. In part 3, subjects were presented again with a list of color names.
These names, however, were not printed in black, but colored (red, yellow, green, and blue) ink in
a way that the ink color never corresponded to the meaning of the word (e.g., “red” printed in green)
and subjects had to identify the ink color. time to complete each part was taken as testing scores.
In the VLMT, subjects had to learn as many words as possible from a spoken list of 15 words
presented in five consecutive trials. Subjects had to recall the words immediately after each trial and
after a 30 min delay. Finally, subjects had to identify the previously learned words from a list which
also included 20 new words and 15 words from an interference list learned during the delay. In sum,
the VLMT allows for the calculation of at least three different memory scores: The “VLMT learning
score” is defined as the sum of correctly recalled words during the five immediate learning trials
(maximum—75 words). The number of correctly recalled words after the 30 min delay (maximum—15
words) is taken as the “VLMT delayed recall score.” Finally, the “VLMT recognition score” comprises
the number of correctly recognized words minus false positive identifications (maximum—15 words).
To avoid test-retest effects, two parallel versions of the VLMT were used and counterbalanced across
groups and time points.
Digit span for- and backwards was measured by the number of digits a subject was able to recall
in correct or reversed order immediately.
Test scores were z-transformed and averaged to create composite scores for each of the cognitive
domains according to van de Rest et al. [34]:
1. Executive functions = [zphonematic fluency + zsemantic fluency − zTMT (part B − part A)/part A −
zStroop (part 3 − (part 1 + part 2))/2]/4;
2. Memory = (zVLMT learning score + zVLMT delayed recall score + zVLMT recognition score + zdigit span backwards)/4;
3. Sensomotor speed = (−zTMT part A − zStroop part A − zStroop part B)/3;
4. Attention = zdigit span forwards.
Changes in affect and mood-related to BARS were also assessed using the Positive and Negative
Affect Schedule (PANAS; [35]) and the State-Trait Anxiety Inventory (STAI; [36]) at t1 and t2. Changes
in health-related quality of life were assessed with a 12-item short-form health survey resulting in
a physical and psychological subscore (SF-12; [37]). To monitor how participants changed physical
activity over time, which might by itself influence brain structure and function [38], we used the
Freiburger Questionnaire on Physical Activity (FKA; [39]) at both time points. In addition, psychiatric
co-morbidity was monitored using the Beck’s Depression Inventory (BDI; [40]). Only at t1, subjects
were also screened for cognitive impairment using the MMSE and general verbal intelligence was
measured using the multiple choice vocabulary test (MWT-B; [41]).
Body fat percentage was computed via bioelectric impedance data analysis performed with
B.I.A. 2000-M (Data Input GmbH, Pöcking, Germany) and the software NutriPlus (Data Input GmbH,
Pöcking, Germany).
Serum levels of glycated hemoglobin A1c (HbA1c), fasting glucose and insulin, triacylglycerides,
total cholesterol, high-to-low density lipoprotein (HDL-to-LDL) ratio, tumor necrosis factor-alpha
(TNF-α), interleukin-6, high-sensitive C-reactive protein (hsCRP), and leptin were analyzed by the
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IMD laboratory, Berlin, Germany. The HOMA index was calculated from fasting glucose and insulin
levels to indicate insulin resistance.
2.4. Statistical Analysis of Neuropsychological and Physical Data
Statistical analysis of neuropsychological data and physical parameters (was performed using
SPSS 23.0 (PASW, SPSS; IBM, Armonk, NY, USA). In the case of skewed distributions (|skewness| > 1),
variables were rank-transformed.
To assess changes in cognitive abilities, mood/affect, health-related quality of life, blood levels,
and anthropometric data over time in subjects of the BARS compared with the waiting list control
group, we computed difference scores for each subject between t1 and t2. Difference scores between
groups were then compared using ANCOVAs with the group allocation (BARS vs. NBARS group and
RYGB vs. VSG/GB group, respectively) as the independent variable. To control for interindividual
variability, baseline score values were entered as covariates. To account for differences in age and
BMI before the intervention, age and BMI at baseline were also added as covariates in all analyses.
We additionally tested for changes over time within each group and calculated post-hoc paired t-tests
for illustration purposes (t1 vs. t2).
Since baseline function measures usually have a high impact on follow-up measures, we tested
group x baseline value interaction terms on the executive functions change score (primary outcome)
and found a significant baseline value × group interaction, indicating that patients with lower baseline
scores showed a greater improvement after the intervention than patients with good performance at
baseline (see in detail Section 3.2). As reported in the Section 3, we found no group x time interaction
with regard to the primary outcome in the main analysis, supporting the hypothesis that BARS
compared to NBARS patients improved in executive control. The significant baseline value x group
interaction, however, suggested that our hypothesis might still be true for poor performers. Therefore,
exploratory post-hoc analyses were computed analyzing marginal effects in: (1) Patients who scored
high; (2) average; and (3) low in executive functions tests at t1 using tertiles of the score.
Finally, to explore the question of whether improvements in executive functions were related
to changes in insulin-glucose metabolism or inflammatory markers, bivariate correlation analyses
were run.
The level of significance was set at α = 0.05 (two-tailed) for analyzing the primary outcome
(composite executive functions score). All secondary analyses were done exploratory. For all ANCOVAs,
we report regression coefficients ß, 95% confidence intervals (CI), ηp2 (partial eta squared) as measures
of effect sizes, and p-values. For analyses of marginal effects, we report mean differences (I–J), 95% CIs,
ηp
2 as measures of effect sizes, and p-values. No adjustments to control for the number of comparisons,
due to multiple hypotheses testing were conducted for the secondary analyses.
2.5. MRI Data Acquisition and Voxel-Based Morphometry
MRI was performed on a Siemens Trio system operating at 3 T and using a 12-channel head
coil. The anatomical scan consisted of 192 slices and was acquired in the sagittal plane using a high-
resolution T1-weighted magnetization-prepared rapid acquisition with gradient echo (MPRAGE)
sequence (TR = 1900 ms, TE = 2.52 ms, a = 9◦, voxel size = 1 × 1 × 1 mm3).
Analysis of high-resolution anatomical images was conducted using the SPM8 voxel-based
morphometry (VBM) toolbox (VBM8; http://dbm.neuro.uni-jena.de/vbm). Since the analysis of
longitudinal anatomical data requires customized processing that considers differences within each
individual separately, data pre-processing was done using a specific batch for longitudinal data analysis
(method as described in Reference [9]). This batch registers baseline and follow-up images of each
subject to the mean of both images and calculates structural differences (i.e., intra-individual changes)
by applying spatial normalization parameters, which were estimated during segmentation of the mean
image, to both images. In detail, data pre-processing with VBM8 comprised the following steps for each
subject: First, baseline and follow-up images (t1, t2) were initially realigned to a T1 template in MNI
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space. Second, a mean image (averaged from t1 and t2) was calculated and raw data (t1 and t2) were
realigned using the mean image as the reference image. Third, images were bias-corrected to account
for signal inhomogeneities, and in the next step, segmented into the different tissue classes (GM,
white matter, cerebrospinal fluid). This segmentation procedure was further refined (1) by accounting
for partial volume effects [42], (2) by using adaptive maximum a posteriori estimations [43], and (3)
by applying a hidden Markov random field model [44]. The resulting tissue maps were spatially
normalized using a specific MNI template derived from 550 healthy control subjects of the IXI database
(http://www.brain-development.org) and linear (12-parameter affine) transformations together with
a non-linear diffeomorphic image registration algorithm (DARTEL; [45]). Spatial normalization
parameters obtained from the segmented mean image were finally applied to the segmentation of the
bias-corrected baseline and follow-up images, which were realigned again. Data were not modulated
(i.e., scaled by the amount of contraction or expansion during normalization), because scaling is not
necessary for longitudinal studies in which the focus is on relative differences between two images of
the same participant [46]. In the last step, GM segments (wp1mr*) representing GM volume or density,
respectively, were smoothed with a 10 mm full-width-at-half-maximum (FWHM; [47]) Gaussian kernel
suitable for small sample sizes [9,48].
For the statistical analysis of VBM data (i.e., individual wp1mr* GM segments), we used
repeated-measures ANOVAs with a flexible factorial design comprising the factors “subject,” “group,”
and “time” testing for group x time interactions as implemented in SPM8. Since it has been found that
image artifacts inducing head motion significantly decrease with changes in BMI [49–51], head motion
measured as mean framewise displacement at both time points (t1 and t2) was entered as a covariate
of no interest. To infer changes in GM volume in the BARS compared to the NBARS group between
t1 and t2, in each analysis two t-contrasts were formulated: (1) BARS group > NBARS groupt2>t1
(indicating an increase in GM volume in the BARS group in comparison with the NBARS group) and
(2) NBARS group > BARS groupt2>t1 (indicating a decrease in the BARS group in comparison with the
NBARS group). After significant group × time interactions were detected, we also looked at changes
in GM volume within each group separately (contrasts: BARS groupt2>t1, BARS groupt1>t2, NBARS
groupt2>t1, NBARS groupt1>t2).
In the analysis of GM volume changes, absolute GM thresholds of 0.2 were used to prevent edge
effects located at the border regions of the tissue maps. Reported changes had p-values < 0.05 after
cluster-wise FWE correction at a cluster-defining threshold of p < 0.005, uncorrected.
For illustrative purposes, we extracted GM values in arbitrary units within the two clusters
identified in the whole brain analysis (a cluster in the left superior temporal gyrus extending to insula
and inferior frontal gyrus and a cluster in the bilateral ventral striatum) using the MarsBaR toolbox for
SPM (marsbar.sourceforge.net).
3. Results
3.1. Baseline Characteristics
Subjects in the BARS and NBARS groups were comparable with regard to age, gender, years of
education, general verbal intelligence measured with the vocabulary test, depression score assessed
with the BDI, and levels of fasting glucose and HbA1c (indicating the level of diabetes; see Table 1(a),
for demographic and baseline characteristics). Subjects in the BARS group, however, had on average
a 4.6 kg/m2 higher BMI than subjects in the NBARS group [95% CI = (1.17, 7.94), t(67) = 2.69, p = 0.01].
In addition to the main BARS vs. NBARS comparison, we compared two subsamples of patients (1)
patients in the BARS and NBARS group who also underwent structural MRI and (2) patients in the BARS
group that underwent a purely restrictive (i.e., VSG/GB group) or combined restrictive-malabsorptive
surgical procedure (i.e., RYGB group). Subjects in both MRI samples were comparable in demographics
and baseline characteristics (see Table 1(b)). Subjects in both surgery groups differed in the percentage
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of women [57% in VSG/GB vs. 88% in RYGB, χ2(1) = 4.68, p = 0.03], but were comparable with regard
to all other demographic and baseline characteristics (see Table 1(c)).
3.2. Changes in Physical and Neuropsychological Parameters
Several physical parameters were improved in the BARS group as compared to controls six
months after surgery. That is, we found group × time interactions in the ANCOVAs, indicating lower
weight and BMI, body fat proportions, as well as a systolic and diastolic blood pressure (for descriptive
statistics, regression coefficients ß, 95% Cis, ηp2s, and p-values, see Table 2).
Additional within group comparisons indicated changes of physical measures in the BARS group,
while same parameters in the NBARS group did not change substantially.
With regard to serum parameters, we found group × time interactions indicating changes over
time in the BARS compared to the NBARS group. In particular, glucose metabolism improved (lower
fasting glucose, fasting insulin, HOMA-index) and triacylglycerides, markers of inflammation (IL-6
and hsCRP), and leptin levels decreased. Within group comparisons showed that all serum parameters
changed in the BARS group, whereas, no substantial change or even an unexpected increase (in leptin
levels) occurred in the NBARS group (see Table 2).
With regard to the primary outcome (composite executive functions score), we found no significant
group × time interaction (see Table 2). However, exploratory within group comparisons showed
improvement of executive functions in the BARS group over time [mean difference = 0.26, 95% CI = (0.07,
0.45), t(33) = −2.75, p = 0.01], which was not evident in the NBARS group [mean difference = −0.05,
95% CI = (−0.22, 0.11), t(26) = 0.67, p = 0.51]. We also found no substantial group × time interactions
for secondary cognitive outcomes. However, ANCOVAs showed an impact of baseline values at t1 on
cognitive changes (i.e., difference scores) in the domains memory [ß = −0.72, 95% CI = (−1.1, −0.4),
ηp
2 = 0.21, p < 0.001], sensomotor speed [ß = −0.3, 95% CI = (−0.6, −0.0), ηp2 = 0.07, p = 0.04], and
attention [ß = −0.6, 95% CI = (−0.9, −0.3), ηp2 = 0.20, p < 0.001], and in addition, a baseline value
× group interaction in the cognitive domain executive functions [ß = −0.39, 95% CI = (−0.7, −0.1),
ηp
2 = 0.10, p < 0.02]. This negative relationship (indicated by a negative ß value) shows that patients
with higher executive functions test scores at t1 showed worse performance at t2, while patients with
lower scores improved after surgery in contrast to subjects in the waiting control group.
To explore whether our hypothesis stating that BARS compared to NBARS patients improve in
executive functions might still be true for poor performers at t1, we split our sample into patients
who scored high, average, and low in executive functions tests at t1 and estimated marginal effects
in each group. This post-hoc analysis confirmed that subjects with poor executive control improved
after BARS compared to patients in the NBARS group [I–J = 0.42, 95% CI = (0.1, 0.7), ηp2 = 0.11,
p = 0.01; see Figure 2], which was not the case for average [I–J = 0.17, 95% CI = (−0.1, 0.4), ηp2 = 0.04,
p = 0.14], and good performers [I–J = 0.02, 95% CI = (−0.24, 0.27), ηp2 = 0.00, p = 0.90]. As hypothesized,
a number of scores indicating mood/affect, and health-related quality of life showed an effect of surgery.
In particular, state anxiety and depressive symptoms were lowered in the BARS compared to the
NBARS group, while physiologic health-related quality of life improved, and patients reported more
frequent physical activities (see Table 2). Within group comparisons confirmed this result and showed
that surgery patients improved in all these variables, while NBARS patients even reported less physical
activity at the follow up investigation [mean change = −0.65, t(19) = 2.29, p = 0.03, 95% CI = (0.06,
1.24)].
To investigate the question of whether improvement in executive functions was related to changes
in insulin-glucose metabolism or inflammatory markers, exploratory correlation analyses in patients of
the BARS group were computed. However, there were no substantial correlations between changes in
blood parameters (i.e., fasting glucose, HbA1c, fasting insulin, HOMA-Index, TNF-α, IL-6, hsCRP)
and executive functions scores.
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Table 2. Changes within and between NBARS and BARS groups [mean (SD) at t1 and t2]. Changes with p ≤ 0.05 within and between groups are indicated by
underscoring the numbers.
Within Groups Between Groups
NBARS Group (n = 29) BARS Group (n = 40) Results of the Multiple Linear Regression
t1 t2 p t1 t2 p ß 95% CI ηp2 p
Anthropometric Parameters
Weight (kg) 133.2 (22.6) 133.5 (21.6) 0.81 141.0 (29.7) 111.0 (25.6) <0.001 a −28.5 (−33.0, −23.9) 0.72 <0.001
BMI (kg/m2) 44.6 (5.7) 44.7 (5.3) 0.84 49.3 (7.8) 38.8 (7.4) <0.001 a −9.9 (−11.3, −8.4) 0.74 <0.001
Body fat percentage (%) 44.6 (8.1) 43.9 (7.9) 0.37 a 46.6 (9.5) 40.3 (7.8) <0.001 a −6.1 (−8.3, −3.9) 0.34 <0.001
Systolic blood pressure (mm Hg) 133.3 (15.1) 130.9 (12.5) 0.27 b 136.3 (15.0) 126.2 (11.8) <0.001 c −7.1 (−12.2, −2.0) 0.12 0.01
Diastolic blood pressure (mm Hg) 90.4 (13.1) 88.2 (9.9) 0.23 b 89.0 (10.0) 83.3 (10.0) <0.001 d −4.3 (−8.6, 0.0) 0.07 0.05
Serum levels
Fasting glucose (mg/dL) 119.2 (34.0) 114.9 (19.3) 0.40 c 127.4 (62.5) 110.8 (41.0) 0.01 −10.3 (−17.4, −3.1) 0.12 0.01
HbA1c (%) 6.1 (1.0) 5.8 (0.6) 0.08 b 6.3 (1.1) 5.9 (1.1) <0.001 −6.1 (−14.7, 2.6) 0.03 0.17
Fasting insulin (µU/mL) 25.5 (17.4) 27.0 (13.2) 0.49 b 29.2 (19.6) 12.4 (7.8) <0.001 a −16.4 (−21.1, −11.8) 0.45 <0.001
HOMA-index 7.9 (6.5) 8.1 (4.5) 0.84 c 9.1 (7.1) 3.3 (2.3) <0.001 b −5.2 (−7.2, −3.3) 0.34 <0.001
Triacylglycerides (mg/dL) 150.0 (59.0) 155.7 (71.5) 0.53 b 176.8 (82.1) 129.5 (42.5) <0.001 −13.0 (−21.7, −4.3) 0.13 0.004
Total cholesterol (mg/dL) 191.9 (35.1) 185.6 (32.3) 0.22 b 194.1 (36.3) 182.5 (36.3) 0.02 −6.4 (−20.5, 7.8) 0.01 0.37
LDL-to-HDL ratio 2.8 (1.2) 2.6 (1.0) 0.12 b 2.6 (0.8) 2.4 (0.7) 0.01 −0.1 (−0.5, 0.2) 0.01 0.39
TNF-α (pg/mL) 7.5 (2.1) 8.0 (2.7) 0.22 b 10.1 (4.0) 8.4 (3.7) 0.01 a −1.0 (−2.6, 0.6) 0.03 0.21
IL-6 (pg/mL 3.2 (1.5) 3.7 (2.0) 0.11 b 3.6 (1.8) 2.8 (1.0) <0.001 a −1.2 (−2.0, −0.4) 0.13 0.004
hsCRP (mg/L) 8.5 (6.9) 9.5 (8.1) 0.28 b 12.9 (11.6) 7.0 (7.8) <0.001 −19.7 (−27.8, −11.7) 0.28 <0.001
Leptin (ng/mL) 12.7 (7.6) 17.0 (11.5) 0.02 c 22.7 (11.8) 12.7 (12.0) <0.001 a −11.9 (−17.7, −6.2) 0.22 <0.001
Test Scores
Executive functions (z-scores) 0.18 (0.6) 0.12 (0.7) 0.51 b −0.21 (0.7) 0.05 (0.5) 0.01 e 0.2 (−0.1, 0.4) 0.04 0.13
Memory (z-scores) 0.09 (0.8) 0.15 (0.6) 0.67 −0.08 (0.9) −0.08 (0.8) 0.95 −0.1 (−0.4, 0.2) 0.01 0.5
Sensomotoric speed (z-scores) −0.18 (0.7) −0.02 (0.8) 0.26 a 0.02 (0.9) 0.12 (0.8) 0.3 0.1 (0.3, 0.4) 0 0.74
Attention (z-scores) 0.19 (1.2) 0.12 (1.1) 0.73 −0.15 (0.9) −0.07 (0.9) 0.6 −0.05 (−0.5, 0.4) 0 0.84
PANAS + 29.14 (6.9) 29.55 (5.8) 0.63 32.26 (7.5) 32.54 (7.6) 0.77 a 0.1 (−2.4, 2.6) 0 0.94
PANAS − 14.07 (4.9) 13.90 (4.2) 0.81 11.90 (1.6) 11.73 (0.7) 0.7 0.1 (−1.5, 1.6) 0 0.91
STAI state anxiety 36.93 (88.5) 38.83 (8.8) 0.22 36.53 (9.1) 33.00 (7.5) 0.02 −4.7 (−8.3, −1.1) 0.1 0.01
STAI trait anxiety 44.18 (11.9) 43.09 (13.2) 0.53 f 43.33 (11.0) 38.13 (10.6) 0.02 g −3.4 (−8.5, 1.7) 0.04 0.18
BDI 14.57 (7.5) 13.87 (10.4) 0.63 e 13.24 (9.9) 6.39 (8.1) <0.001 f −6.5 (−10.4, −2.5) 0.18 0.002
SF-12 physiologic 39.44 (11.2) 40.23 (11.4) 0.67 g 34.31 (10.8) 45.21 (10.3) <0.001 g 9.2 (4.0, 14.3) 0.23 0.001
SF-12 psychologic 45.65 (11.8) 45.81 (12.8) 0.96 g 47.27 (12.4) 51.18 (11.6) 0.18 g 1.3 (−5.4, 8.0) 0 0.7
FKA 2.70 (1.6) 2.05 (1.1) 0.03 h 2.58 (1.5) 2.84 (1.2) 0.26 h 0.9 (0.2, 1.5) 0.15 0.01
a Data was not available for one subject. b Data was not available for two subjects. c Data was not available for three subjects. d Data was not available for four subjects. e Data was not
available for six subjects. f Data was not available for seven subjects. g Data was not available for ten subjects. h Data was not available for nine subjects.
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3.3. Changes in GM Volume
Analyzing changes in GM volume, we found a group x time interaction, indicating an increase of
volume over time in the BARS compared to the BARS group (BARS group > NBARS groupt2>t1) in
the left superior temporal gyrus, extending to insula and inferior frontal gyrus (for coordinates, see
Table 3(a) and Figure 3).
In the complementary contrast (BARS group > NBARS groupt1>t2), there were no substantial GM
changes after cluster-wise FWE-correction. Applying a voxel-wise small volume FWE-correction (SVC)
using an a priori defined ROI of the bilateral nucleus accumbens; however, we found decreased GM
volume over time in BARS patients as compared to the NBARS group (group × time interaction; for
intragroup comparisons: t2 > t1 and t1 > t2 in the BARS and NBARS groups, see Table 3(b) and (c).
3.4. Differences between Surgical Procedures
The ANCOVAs testing for differences between patients who underwent either RYGB (combined
restrictive-malabsorptive, RYGB group) or VSG/GB (purely restrictive, VSG/GB group) surgery, only
revealed few substantial group × time interactions, indicating a greater weight loss (weight and BMI)
in patients of the RYGB compared to the VSG/GB group (see Table 4). Patients of the RYGB group also
showed a greater decrease in fasting insulin, HOMA-index, and total cholesterol than VSG/GB patients.
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Table 3. Results of the whole-brain voxel-based GM volume analyses showing (a) group × time
interactions and within-group comparisons over time (b) and (c); BARS group: n = 13; NBARS group:
n = 14). Reported clusters were cluster-wise FWE-corrected at p < 0.05 at a cluster-defining uncorrected
threshold of p < 0.005.
Anatomical Region L/R Number ofVoxels in Cluster
Z score of Local
Maximum
MNI Peak Voxel
Coordinates
x y z
(a) Group x Time interactions
BARS group > NBARS groupt2>t1
(indicating an increase of volume in the surgery
compared to the control group)
Superior temporal gyrus, insula, inferior
frontal gyrus L 3566 3.97 −44 −13 −3
BARS group > NBARS groupt1>t2
(indicating a decrease of volume in the surgery
compared to the control group)
Nucleus accumbens * L 78 3.32 −8 6 −6
(b) Within surgery group comparisons
BARS groupt2>t1 (indicating an increase)
Middle occipital gyrus, supramarginal gyrus L 3175 3.74 −30 −70 25
BARS groupt1>t2 (indicating a decrease)
No ROI, nucleus putamen L 8877 4.84 −9 4 −15
Supramarginal gyrus, cerebellum R 2586 4.43 62 −42 30
No ROI, medial inferior occipital cortex L 3004 3.85 −26 −102 −9
(c) Within control group comparisons
NBARS groupt2>t1 (indicating an increase) No suprathreshold clusters
NBARS groupt1>t2 (indicating a decrease) No suprathreshold clusters
* Voxel-wise small volume corrected (SVC) using an a priori defined ROI of the bilateral nucleus accumbens obtained
from the Automated Anatomical Labeling ROI library (AAL; [52]). L = left hemisphere; R = right hemisphere.Nutrients 2020, 12, x FOR PEER REVIEW 14 of 20 
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Figure 3. Changes in GM volume over time in the BARS grou 13) compared wit the NBARS
group (n = 14). Left panel: (A) Yellow-red brain regions sho an increase in GM volume over time in
the BARS compared to the NBARS group (contrast: BARS group > NBARS groupt2>t1). (B) Yellow-red
brain regions show a decrease in gray matter volume over time in the BARS compared to the NBARS
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95% confidence intervals) showing GM volume in arbitrary units plotted for both groups in the left
superior temporal gyrus extending to insula and inferior frontal gyrus (A) and the bilateral ventral
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Table 4. Changes within and between VSG/GB and RYGB groups [mean (SD) at t1 and t2]. Changes with p ≤ 0.05 within and between groups are indicated by
underscoring the numbers.
Within Groups Between Groups
VSG/GB Group (n = 23) RYGB Group (n = 17) Results of the Multiple Linear Regression
t1 t2 p t1 t2 p ß 95% CI ηp2 p
Anthropometric Parameters
Weight (kg) 148.3 (29.8) 120.0 (24.6) <0.001 a 131.6 (27.5) 99.44 (22.4) <0.001 −6.7 (−12.8, −0.6) 0.13 0.03
BMI (kg/m2) 50.5 (8.6) 41.0 (7.9) <0.001 a 47.7 (6.5) 36.0 (5.6) <0.001 −2.3 (−4.2, −0.4) 0.15 0.02
Body fat percentage (%) 44.3 (11.3) 39.4 (9.2) 0.001 a 49.5 (5.2) 41.4 (5.6) <0.001 −0.8 (−3.7, 2.1) 0.01 0.59
Systolic blood pressure (mm Hg) 135.3 (13.8) 128.1 (10.5) 0.02 a 137.7 (17.1) 123.6 (13.4) <0.001 b −5.4 (−12.0, 1.2) 0.08 0.11
Diastolic blood pressure (mm Hg) 87.6 (9.8) 84.2 (9.7) 0.06 a 90.0 (10.7) 81.5 (10.3) 0.002 b −4.2 (−9.9, 1.5) 0.07 0.14
Serum Levels
Fasting glucose (mg/dL) 133.8 (79.2) 113.8 (49.3) 0.02 118.7 (27.7) 106.7 (27.0) 0.18 1.1 (−3.7, 5.9) 0.01 0.65
HbA1c (%) 6.3 (1.1) 6.0 (1.2) 0.001 6.2 (1.0) 5.8 (0.8) 0.003 −0.1 (−0.4, 0.2) 0.01 0.56
Fasting insulin (µU/mL) 29.0 (20.1) 13.7 (8.5) <0.001 29.6 (19.6) 10.27 (6.2) <0.001 a −3.8 (−6.9, −0.7) 0.16 0.02
HOMA-index 8.8 (6.7) 3.7 (2.1) <0.001 a 9.4 (7.8) 2.8 (2.5) <0.001 a −3.0 (−4.8, −1.2) 0.26 0.002
Triacylglycerides (mg/dL) 200.1 (91.6) 141.7 (45.2) 0.01 145.2 (55.3) 112.9 (32.9) <0.001 −2.5 (−7.8, 2.7) 0.03 0.34
Total cholesterol (mg/dL) 197.9 (40.4) 193.7 (35.9) 0.49 189.0 (30.1) 167.4 (32.0) 0.01 −20.6 (−38.7, −2.5) 0.13 0.03
LDL-to-HDL ratio 2.7 (0.8) 2.5 (0.7) 0.16 2.5 (0.9) 2.2 (0.7) 0.04 −0.2 (−0.6, 0.1) 0.04 0.22
TNF-α (pg/mL) 10.3 (3.7) 8.3 (3.0) 0.03 9.7 (4.4) 8.6 (4.6) 0.07 a 0.8 (−1.3, 2.9) 0.02 0.45
IL-6 (pg/mL 3.7 (2.1) 2.8 (1.1) 0.02 3.4 (1.3) 2.7 (0.9) 0.02 a −1.1 (−6.5, 4.4) 0.01 0.69
hsCRP (mg/L) 12.6 (10.8) 8.0 (8.6) 0.003 13.3 (13.0) 5.5 (6.4) 0.003 −2.9 (−8.7, 3.0) 0.03 0.32
Leptin (ng/mL) 23.7 (13.3) 15.2 (13.6) 0.002 a 21.4 (9.7) 9.4 (8.7) <0.001 −4.4 (−11.0, 2.1) 0.05 0.18
Test Scores
Executive functions (z-scores) −0.10 (0.7) 0.20 (0.6) 0.03 c −0.15 (0.8) 0.06 (0.5) 0.17 a −0.2 (−0.4, 0.1) 0.04 0.3
Memory (z-scores) −0.23 (0.8) −0.23 (0.8) 0.98 0.31 (0.9) 0.32 (0.5) 0.96 5.1 (−1.6, 11.7) 0.07 0.13
Sensomotoric speed (z-scores) −0.07 (1.0) 0.03 (0.8) 0.92 −0.01 (0.7) 0.07 (0.7) 0.88 −0.0 (−0.4, 0.3) 0 0.84
Attention (z-scores) −0.22 (1.0) −0.20 (0.9) 0.92 0.19 (0.9) 0.37 (1.1) 0.47 0.4 (−0.2, 1.0) 0.05 0.21
PANAS + 33.04 (8.2) 33.96 (8.6) 0.5 31.13 (6.5) 30.50 (5.6) 0.63 a −2.2 (−5.7, 1.3) 0.05 0.22
PANAS − 12.09 (1.8) 11.04 (1.5) 0.01 11.65 (1.3) 12.65 (4.0) 0.27 5.4 (−1.0, 11.7) 0.08 0.1
STAI state anxiety 35.96 (9.3) 30.78 (7.2) 0.01 37.29 (9.1) 36.00 (6.9) 0.55 3.8 (−0.5, 8.1) 0.09 0.08
STAI trait anxiety 43.20 (12.5) 35.93 (10.4) 0.01 42.71 (9.6) 41.43 (10.2) 0.58 d 5.8 (−0.5, 12.0) 0.13 0.07
BDI 14.50 (10.6) 6.88 (8.8) 0.001 11.94 (9.7) 6.25 (7.7) 0.01 a −0.2 (−4.6, 4.2) 0 0.92
SF-12 physiologic 31.72 (8.1) 45.61 (8.7) <0.001 38.07 (13.1) 43.93 (12.2) 0.04 e −5.4 (−11.9, 1.0) 0.11 0.1
SF-12 psychologic 47.55 (13.5) 51.98 (11.4) 0.23 48.00 (11.3) 49.69 (12.5) 0.57 e −0.9 (−8.3, 6.5) 0 0.8
FKA 2.94 (1.6) 3.19 (1.4) 0.43 2.20 (1.4) 2.47 (1.0) 0.43 b −0.3 (−1.1, 0.5) 0.02 0.47
a Data was not available for one subject. b Data was not available for two subjects. c Data was not available for five subjects. d Data was not available for three subjects. e Data was not
available for four subjects.
Nutrients 2020, 12, 127 14 of 20
Surgery groups, however, did not differ substantially with regard to changes in cognitive functions,
mood/affect, and health-related quality of life. In contrast to our hypotheses, exploratory within-group
comparisons showed a number of changes in the VSG/GB group [an increase in the executive functions
test score: Mean change = 0.30, 95% CI = (1.80, 2.87), t(17) = −2.40, p = 0.03, a decrease in negative
affect: Mean change = −1.04, 95% CI = (1.80, 2.87), t(22) = 2.87, p = 0.01, as well as a decrease in
state and trait anxiety: Mean change = −5.17, 95% CI = (1.44, 8.90), t(22) = 2.88, p = 0.01 and mean
change = −7.27, 95% CI = (2.29, 12.24), t(14) = 3.13, p = 0.01], which were not seen in the RYGB group.
Finally, the subgroup analysis did not reveal substantial baseline value × group interactions in any of
the cognitive domains, in contrast to what could be seen in the BARS vs. NBARS group comparisons.
4. Discussion
In this longitudinal observational study, we investigated the effects of BARS on cognitive functions,
mood, health-related quality of life, as well as on serum and anthropometric parameters. To further
study the neural correlates underlying the putative changes in brain health, we analyzed changes in
GM volume in a subsample eligible for MRI scanning and compared patients who underwent either
RYGB (combined restrictive-malabsorptive) or VSG/GB (purely restrictive) surgery.
The study yielded three main results: First, no important differences in cognitive functions
between BARS and NBARS group emerged; however, exploratory analyses revealed improvement
in executive functions, particularly in patients who performed poorly at baseline. In addition to
previously well-documented changes in weight, body fat proportions, and serum parameters of glucose
metabolism and inflammation, we found significant improvements in mood/affect and quality of life
in patients who underwent BARS as compared to the waiting list controls. Second, BARS patients
showed an increase of GM volume in fronto-temporal brain areas accompanied by a reduction of
volume in the nucleus accumbens. Third, we found that patients who underwent RYGB surgery had
greater weight loss as compared to patients with purely restrictive treatment, yet did not benefit more
in terms of cognitive performance. In addition, no association was found between cognitive changes
and changes in glucose metabolism or inflammation parameters.
4.1. Effects of BARS on Cognitive Functions
In the present study, we did not find any substantial improvement in cognitive functions (primary
and secondary outcomes) in patients of the BARS as compared to the NBARS group. This result was
surprising in light of previous studies demonstrating the beneficial effects of weight loss after BARS
on cognitive performance [19,20]. The only indication that BARS might have a beneficial effect on
executive control [15] was seen in the exploratory post-hoc within-group analysis, and a between-group
comparison, including subjects with low performance at baseline only, which could also be a statistical
“regression to the mean”. The present study could also not replicate the finding of weight loss-induced
recognition memory improvement reported in previous studies of our group (cf. References [9,53]).
The lack of substantial changes in cognitive scores might be due to the fact that we used a test
battery mainly constructed for clinical use (i.e., for identifying older patients with mild cognitive
impairment). Patients in our study, however, were rather young (mean age = 45.5 years, range
from 26 to 68) and demonstrated baseline performance in the normal to high-normal range, which
might have obscured improvements. The hypothesis that more sensitive experimental tasks might
have yielded differential changes between groups is supported by the post-hoc analysis showing
improvement in executive functions in patients who performed poorly at baseline.
Despite the lack of significant changes in cognitive scores, we found surgery-related improvement
in mood, affect, and health-related quality of life. In particular, state anxiety and depressive symptoms
were decreased, while physiologic well-being and physical activity increased. The reduction in
depressive symptoms and anxiety are known to accompany weight loss in overweight individuals [54],
and might be related to the experience of success in losing weight.
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Although we noted improvements after BARS in several physical parameters, indicating
improvements in cardiovascular risk factors (e.g., decreases in total weight, systolic and diastolic blood
pressure, and improvements in glucose metabolism and inflammation), we were not able to link these
changes to the improvements in executive functions (cf. References [23,55]).
4.2. Effects of BARS on Brain Structure
With regard to brain structural changes, we found an increase in GM volume in the left superior
temporal gyrus, extending to insula and inferior frontal gyrus over time in the BARS as compared to
the NBARS group (group × time interaction). Increased GM volume in patients of the BARS group
might reflect increased synaptic connectivity and dendritic arborization, which has also been observed
following cognitive and behavioral training interventions [56,57]. Similar changes have been reported
after intense weight loss following a low-caloric diet [9], and after BARS [58,59]. Tuulari et al. [58],
for instance, found an increase of global white matter density six months after surgery, as well as an
increase of GM volume in occipital and inferior temporal brain regions. Another study by Liu et al. [60]
investigated cortical thickness before and one month after BARS and reported a number of increases
and decreases in various brain regions, which are thought to be implicated in executive control and
self-referential processing, including the frontal, temporal, and cingulate cortex.
Notably, substantial weight loss-induced changes in brain structure were found, although we were
not able to provide evidence for changes in cognitive functions. This result underscores the usefulness
of sensitive biomarkers when uncovering intervention-related improvements in brain health. Changes
in GM volume and functional neural networks might become apparent some time before changes in
downstream cognition occur [27,28]. To also detect changes in cognitive function scores, we, therefore,
suggest conducting future studies, including later follow-up measurements.
In addition to expected changes in fronto-temporal brain regions, we found a decrease of GM
volume in the bilateral ventral striatum (i.e., the nucleus accumbens) in the BARS compared to the
NBARS group. Since brain structures of the mesolimbic reward system are increased in volume in
obesity (e.g., Reference [61]), (for a review, see Reference [62]), a decrease after BARS could indicate
changes that accompany a modified and more healthy eating behavior. Eating fewer calories overall,
and smaller portions, reduces the chronically enhanced neural activity in these brain regions [63,64],
which will translate into a decrease of volume over time.
4.3. Influence of Surgical Procedure on Cognitive Performance
BARS provides an excellent interventional approach for studying the effects of weight loss on
brain health. As described in the Introduction, BARS comprises different surgical procedures using
either purely restrictive (VSG/GB) or combined restrictive- malabsorptive approaches (RYGB). Since
patients treated with RYGB demonstrate greater and more rapid weight loss than patients treated with
other procedures [22], beneficial effects of BARS on cognitive functions should be greater in the RYGB
compared to the VSG/GB group. In line with this assumption, we found differences in weight, BMI,
and glucose metabolism. However, no differences between groups over time in cognitive test scores
were noted. We speculate that the lack of evidence for greater cognitive benefits of RYGB surgery might
be related to greater side effects of this approach: Due to the strong modification of the gastrointestinal
tract, patients face several restrictions (e.g., life-long vitamin supplementation and the need to follow
strict dietary guidelines), which may considerably impair their quality of life [65,66]. The hypothesis
that small cognitive improvements might be masked by side effects still needs to be evaluated in
further studies. The lack of influence of the amount of weight loss on cognitive performance, moreover,
is in line with previous studies of our group demonstrating improved cognitive performance already
after moderate weight loss [53].
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4.4. Limitations
Some limitations should be considered when interpreting our findings. First, the sample size in
our study was rather small; although comparable to sample sizes from previous studies [15,67–69].
While including 40 subjects in the BARS group, we were only able to analyze the data of 29 subjects
in the waiting list control group, due to recruitment difficulties and many drop-outs, especially in
the NBARS group (BARS: n = 5; NBARS: n = 7). Therefore, we cannot fully exclude the possibility
that a lack of statistically significant changes between t1 and t2 in cognitive parameters is due to
the small number of participants. Thus, further studies are needed to replicate our results in larger
samples. In particular, the analysis comparing cognitive outcomes between surgical procedures must
be considered as preliminary. Moreover, the size of the MRI sample in our study was too small for
computing correlational analyses or subgroup analyses comparing the two surgical groups. Since
many patients did not fit into the scanner, we recommend using a scanner with a larger bore than the
one implemented in the Siemens Trio system in further studies.
Second, it must be noted that our study population was rather heterogeneous. As described in
Section 2, on methods, we included men and women with an age range from 26 to 68 years. To control
for the effects of some covariates, we entered age, BMI, and baseline test scores in the statistical analyses.
However, we still cannot exclude that improvements in cognitive scores were not detected because
they were overlaid by sample heterogeneities.
Third, the present study is an observational study in which no blinding (neither of patients nor
investigators) was possible. Moreover, subjects in the waiting list control group might have been
frustrated, since their application for cost coverage by the health insurance company was still not
approved, and they struggled with bureaucratic obstacles to attain this approval. Therefore, we cannot
rule out that group-specific improvement in executive functions after surgery might be in part, due to
motivation deficits in the waiting list control group. However, given that improvements in executive
functions were also evident in paired t-tests within the BARS group, and paralleled by changes in brain
structure, we consider this explanation as unlikely.
4.5. Conclusion and Outlook
Obesity represents a major health problem, since it increases the risk for a number of adverse
conditions, including type 2 diabetes, coronary heart disease, stroke, and dementia. Since BARS leads to
rapid and sustainable weight loss, it might be an excellent approach to promote not only cardiovascular,
but also brain health. In the present longitudinal observational study, we analyzed changes in
a comprehensive neuropsychological test battery in patients six months after BARS compared to
a well-matched waiting list control group during a similar period of time. We found expected beneficial
changes in weight and serum parameters, as well as substantial group differences in brain structure.
These changes, however, did not (yet) translate into improved cognition, although we found some
indication for improved executive control after BARS, particularly in low baseline performers. Future
studies should evaluate the benefits of effectively treating obesity on brain health with more sensitive
measures and longer follow-up periods. To specifically investigate the effect/advantage of BARS
compared to other means inducing weight loss on brain health, future studies should include an
additional study group of patients that lose weight through a lifestyle modification program.
Moreover, our study investigated for the first time, in an exploratory approach, whether different
surgical procedures (purely restrictive vs. combined restrictive-malabsorptive) vary in long-term
cognitive outcomes. As expected, RYGB patients demonstrated greater weight loss than patients
with restrictive treatment alone. However, they did not benefit more in terms of cognitive functions.
Given that no differences in cognition over time between surgical procedures emerged, our study
does not support combined restrictive-malabsorptive approaches, that offer larger weight loss and
more improvement on glucose metabolism, but also carry greater risks and disadvantages, such as
lifelong vitamin supplementation and the need to follow strict diet guidelines to avoid vomiting and
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diarrhea [10,70]. Since the sample size was rather small, in particular for computing the subgroup
analysis, further studies with greater sample sizes are needed to replicate this result.
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